Abstract:Transition metal complexes exhibiting selective toxicity towards a broad range of cancer types are highly desirable as potential anticancer agents. Herein, we report the synthesis, characterization, and cytotoxicity studies of six new mixed-ligand cobalt(III) complexes of general formula [Co(B)2(L)](ClO4)2 (1–6), where B is a N,N-donor phenanthroline base, namely, 1,10-phenanthroline (phen in 1, 2), dipyrido[3,2-d:2',3'-f]quinoxaline (dpq in 3, 4), and dipyrido[3,2-a:2',3'-c]phenazine (dppz in 5, 6), and L is the monoanion of 8-hydroxyquinoline (HQ in 1, 3, 5) and 5-Chloro-7-iodo-8-hydroxyquinoline (CQ in 2, 4, 6). The X-ray single crystal structures of complexes 1 and 2 as PF6- salts revealed a distorted octahedral CoN5O coordination environment. Complexes demonstrated good stability in an aqueous buffer medium and in the presence of ascorbic acid as a reductant. Cytotoxicity studies using a panel of nine cancer cell lines showed that complex 6, with the dppz and CQ ligands, was significantly toxic against most cancer cell types, yielding IC50 values in the range of 2 to 14 μM. Complexes 1, 3, and 5, containing the HQ ligand, displayed lower toxicity compared to their CQ counterparts. The phenanthroline complexes demonstrated marginal toxicity towards the tested cell lines, while the dpq complexes exhibited moderate toxicity. Interestingly, all complexes demonstrated negligible toxicity towards normal HEK-293 kidney cells (IC50 > 100 μM). The observed cytotoxicity of the complexes correlated well with their lipophilicities (dppz > dpq > phen). The cytotoxicity of complex 6 was comparable to that of the clinical drug cisplatin under similar conditions. Notably, neither the HQ nor the CQ ligands alone demonstrated noticeable toxicity against any of the tested cell lines. The Annexin-V-FITC and DCFDA assays revealed that the cell death mechanism induced by the complexes involved apoptosis, which could be attributed to the metal-assisted generation of reactive oxygen species. Overall, the dppz complex 6, with its remarkable cytotoxicity against a broad range of cancer cells and negligible toxicity toward normal cells, holds significant potential for cancer chemotherapeutic applications.

Strong in vitro and vivo cytotoxicity of three new cobalt(II) complexes with 8-methoxyquinoline

Bio-relevant Cobalt(ii) Complexes with Compartmental Polyquinoline Ligand: Synthesis, Crystal Structures and Biological Activities.

Cobalt(ii) 8-Hydroxyquinoline Complexes: Structure, Cytotoxicity and Action Mechanism

Synthesis, characterization, and cancer cell-selective cytotoxicity of mixed-ligand cobalt(III) complexes of 8-hydroxyquinolines and phenanthroline bases

Synthesis, Characterization and Biological Evaluation of a Cobalt(ii) Complex with 5‐chloro‐8‐hydroxyquinoline As Anticancer Agent

Synthesis, Toxicity and Antitumor Activity of Cobalt Carbonyl Complexes Targeting Hepatocellular Carcinoma.

Novel Cyclometalated Ru(II) Complexes Containing Isoquinoline Ligands: Synthesis, Characterization, Cellular Uptake and in Vitro Cytotoxicity.

Cytotoxic cobalt (III) Schiff base complexes: in vitro anti-proliferative, oxidative stress and gene expression studies in human breast and lung cancer cells

Toxicity, bio-distribution and metabolism of CO-releasing molecules based on cobalt.

Dithiocarbazate–Fe III , −Co III , −Ni II , and −Zn II Complexes: Design, Synthesis, Structure, and Anticancer Evaluation

[Toxicology and Bioactivities of CO-releasing Molecules Based on Cobalt Complexes].

Insights into the antineoplastic activity and mechanisms of action of coumarin-coordinated 8-hydroxyquinoline ruthenium(II/III) compounds

New dinuclear cobalt (II) complexes as "self‐activating" chemical nuclease and inhibitor of tumor cell invasion: high selective cytotoxicity against NCI‐H460 cells

DNA Binding and in Vitro Anticarcinogenic Activity of a Series of Newfashioned Cu(II)-complexes Based on Tricationic Metalloporphyrin Salicyloylhydrazone Ligands.

Synthesis and evaluation of stable bidentate transition metal complexes of 1-(chloromethyl)-5-hydroxy-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinoline (seco-6-azaCBI-TMI) as hypoxia selective cytotoxins.

Novel Cytotoxic Copper(II) Complexes of 8‐aminoquinoline Derivatives: Crystal Structure and Different Reactivity Towards Glutathione

Dna-Binding and Anti-Tumor Activities of Cobalt Corrole Complexes

Β-Diketone-cobalt Complexes Inhibit DNA Synthesis and Induce S-phase Arrest in Rat C6 Glioma Cells.

Synthesis, cytotoxicity and DNA binding of novel Ni(II), Co(II) and Zn(II) complexes bearing pyrimidinyl hydrazone ligand

Synthesis, crystal structures and anticancer studies of Ni (II), Co (III) and Zn (II) complexes based on 5-bromosalicylaldehyde- 2-(2-aminophenyl)benzimidazole Schiff base

Coordination environment dependence of anticancer activity in cyclometalated bismuth(III) complexes with C,O-chelating ligands